United States · Series B startup

Who invested in Ascletis

4 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$255Mraised across 4 rounds since 2011, from 4 sources

$100MSeries A$35MSeries B$20MSeries C$100MSeries B
Latest round
Series B, $100MJan 2017
Step-upi
5×
Investors
5
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2011201220132014201520162017
$100MSeries A$35MSeries B$20MSeries C$100MSeries B
First round
Series A, $100M
Apr 2011
Biggest round
$100M
Series B · Jan 2017
Usual gap between rounds
13 months
the median of 3

The rounds

  1. Jan 2017
    Series B$100M2 returning

    Reported by Fiercebiotech

  2. Dec 2015
    Series C$20M1 new

    From a historical funding record

  3. Sept 2015
    Series B$35M3 new

    From a historical funding record

  4. Apr 2011

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Goldman SachsPrivate equity2rounds
C-Bridge CapitalGrowth equity2rounds
Pavillion CapitalGrowth equity1round
Tasly PharmaceuticalCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Ascletis

Who invested in Ascletis?

Ascletis's investors include Goldman Sachs, C-Bridge Capital, Pavillion Capital, Tasly Pharmaceutical and Hangzhou Binjiang Investment Holding.

How much has Ascletis raised?

Ascletis has raised $255M across 4 rounds since 2011.

When did Ascletis last raise?

Ascletis's most recent round was a Series B of $100M in Jan 2017.

What was Ascletis's biggest round?

Its most recent round, $100M in Jan 2017, is also its largest on record.

Who backed Ascletis first?

Ascletis's first round on record, in Apr 2011, was backed by Hangzhou Binjiang Investment Holding.

What stage is Ascletis at?

Ascletis's latest named round is a Series B, in Jan 2017.

Where is Ascletis based?

Ascletis is based in the United States.

Companies like Ascletis

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.